Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/25189
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | BUYSE, Marc | - |
dc.contributor.author | Saad, E. | - |
dc.contributor.author | BURZYKOWSKI, Tomasz | - |
dc.date.accessioned | 2017-11-15T13:37:55Z | - |
dc.date.available | 2017-11-15T13:37:55Z | - |
dc.date.issued | 2016 | - |
dc.identifier.citation | NEW ENGLAND JOURNAL OF MEDICINE, 375(16), p. 1591-1592 | - |
dc.identifier.issn | 0028-4793 | - |
dc.identifier.uri | http://hdl.handle.net/1942/25189 | - |
dc.language.iso | en | - |
dc.rights | Copyright © 2016 Massachusetts Medical Society. All rights reserved. | - |
dc.title | Adaptive Randomization of Neratinib in Early Breast Cancer | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 1592 | - |
dc.identifier.issue | 16 | - |
dc.identifier.spage | 1591 | - |
dc.identifier.volume | 375 | - |
local.bibliographicCitation.jcat | A1 | - |
local.type.refereed | Refereed | - |
local.type.specified | Letter | - |
local.class | dsPublValOverrule/internal_author_not_expected | - |
local.class | IncludeIn-ExcludeFrom-List/ExcludeFromFRIS | - |
dc.identifier.doi | 10.1056/NEJMc1609993 | - |
dc.identifier.isi | 000393102500018 | - |
item.contributor | BUYSE, Marc | - |
item.contributor | Saad, E. | - |
item.contributor | BURZYKOWSKI, Tomasz | - |
item.accessRights | Restricted Access | - |
item.fullcitation | BUYSE, Marc; Saad, E. & BURZYKOWSKI, Tomasz (2016) Adaptive Randomization of Neratinib in Early Breast Cancer. In: NEW ENGLAND JOURNAL OF MEDICINE, 375(16), p. 1591-1592. | - |
item.validation | ecoom 2018 | - |
item.fulltext | With Fulltext | - |
crisitem.journal.issn | 0028-4793 | - |
crisitem.journal.eissn | 1533-4406 | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
nejmc1609993.pdf Restricted Access | Published version | 89.53 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.